Key result
RACK1 preferentially binds NHERF1 PDZ1 over PDZ2 without affecting cAMP-dependent CFTR activation.
Why the study?
The specific binding site of RACK1 on NHERF1 and its functional implications in airway epithelial cells were not fully characterized.
RACK1 binds predominantly to the PDZ1 domain of NHERF1 at a site encompassing the GYGF loop, which is distinct from the PKC-epsilon binding site.
Defines RACK1-NHERF1 binding site; extends in vitro CFTR regulation data but leaves open physiologic relevance.
In past studies, we demonstrated regulation of CFTR Cl channel function by protein kinase C (PKC)-epsilon through the binding of PKC-epsilon to RACK1 (a receptor for activated C-kinase) and of RACK1 to human Na(+)/H(+) exchanger regulatory factor (NHERF1). In this study, we investigated the site of RACK1 binding on NHERF1 using solid-phase and solution binding assays and pulldown, immunoprecipitation, and (36)Cl efflux experiments. Recombinant RACK1 binding to glutathione S-transferase (GST)-tagged PDZ1 domain of NHERF1 was 10-fold higher than its binding to GST-tagged PDZ2 domain of NHERF1. PDZ1 binds to RACK1 in a dose-dependent manner and vice versa, with similar binding constants of 1.67 and 1.26 microg, respectively. Interaction of the PDZ1 domain with RACK1 was not blocked by binding of activated PKC-epsilon to RACK1. A GST-tagged PDZ1 domain pulled down endogenous RACK1 from Calu-3 cell lysate. An internal 11-amino acid motif embedding the GYGF carboxylate binding loop of PDZ1 binds to RACK1, inhibits binding of recombinant NHERF1 and RACK1, pulls down endogenous RACK1 from Calu-3 cell lysate, and blocks coimmunoprecipitation of endogenous RACK1 with endogenous NHERF1 but does not affect cAMP-dependent activation of CFTR. A similar amino acid sequence in the PDZ2 domain did not bind RACK1. Our results indicate binding of Calu-3 RACK1 predominantly to the PDZ1 domain of NHERF1 at a site encompassing the GYGF loop of the PDZ1 domain and a site on RACK1 distinct from a PKC-epsilon binding site. CFTR activation by cAMP-generating agent is not affected by loss of RACK1-NHERF1 interaction.
No takes yet. Share an insight, caveat, or question.
Liedtke et al. (2004) studied CFTR regulation. PDZ1 domain of NHERF1 vs. PDZ2 domain of NHERF1 was evaluated on RACK1 binding. RACK1 binds predominantly to the PDZ1 domain of NHERF1 rather than the PDZ2 domain, but loss of this interaction does not affect cAMP-dependent activation of CFTR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: